Roger Mack Hinson - Aug 10, 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Pres., PDX & OBX Medical Group
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Aug 10, 2021
Transactions value $
-$284,648
Form type
4
Date filed
8/11/2021, 05:01 PM
Next filing
Nov 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale -$285K -8.8K -7.04% $32.35 116K Aug 10, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales made pursuant to reporting person's 10b5-1 trading plan adopted June 15, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in thirty-six (36) separate transactions with prices ranging from $32.01 to $32.67 for an average weighted sale price of $32.35. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 Includes 128 shares acquired by the Reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing.